TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07144345: Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp

Sponsor: Sun Pharmaceutical Industries, Inc. · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 160 pts

Competing Trials Overlap

8 Active Trials

Excess Burn Exposure

$2,074,336

Rescue Site Savings

+$1,367,176

Unlock Full NCT07144345 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07144345 Rescue Dossier →